John Smyth Sees 925,342 Orange Minerals Performance Rights Expire Across Six Categories

Six Classes of Performance Rights Expire for John Smyth on 29 June 2026

The key event disclosed is the expiration of performance rights held indirectly by Orange Minerals director John Campbell Smyth via Clariden Capital Limited. On 29 June 2026, 925,342 performance rights across six classes lapsed. This formal "lapsing of performance rights" indicates these rights expired without conversion into ordinary shares.

The six classes affected include: 136,624 Class A; 136,624 Class B; 191,056 Class C; 243,310 Class D; 108,864 Class E; and 108,864 Class F performance rights. Together, these represent a complete elimination of the performance rights held through Clariden Capital Limited. No cash or other consideration was received by Smyth or Clariden Capital Limited upon expiration.

Implications of Performance Rights Lapsing Under Australian Law

Australian law and ASX Listing Rules require directors to notify the exchange of changes to their relevant interests, including lapsing or expiry of performance rights, under Listing Rule 3.19A.2 and section 205G of the Corporations Act. Orange Minerals complied by lodging an Appendix 3Y form detailing Smyth's holdings before and after the change.

Performance rights are common equity-based incentives in ASX-listed companies, especially in resources and exploration. They vest upon meeting specific performance conditions or milestones. If these are unmet within the timeframe, the rights lapse with no value to the holder. The announcement does not disclose the performance conditions tied to Classes A through F or reasons for the lapse.

Smyth’s Direct Holdings via Smyth Super Fund Remain Substantial

Despite the lapse of performance rights held indirectly, Smyth maintains a significant direct stake through his superannuation fund, the Smyth Super Fund, holding 10,500,000 fully paid ordinary shares. This position was unaffected by the lapsing event.

Additionally, the Smyth Super Fund holds 2,000,000 unlisted options exercisable at $0.09 per share until 15 July 2027. These options retain value only if Orange Minerals’ share price exceeds $0.09 before expiry, allowing Smyth continued equity-linked upside despite the performance rights lapse. The immediate share price impact is not publicly known.

Post-Lapse Indirect Holdings via Clariden Capital Limited

Before 29 June 2026, Clariden Capital Limited held both ordinary shares and six classes of performance rights. After the lapse, all performance rights held by Clariden Capital Limited have been extinguished, leaving only 4,500,000 fully paid ordinary shares in Orange Minerals NL.

This change means Smyth’s indirect interest through Clariden Capital Limited is now solely an ordinary shareholding, removing performance-based instruments and simplifying future disclosures. However, it also reduces Smyth’s overall equity-linked incentives via this entity.

Cornerstone Advisors Pty Ltd Holdings Unaffected

The update confirms Smyth holds indirect interests through Cornerstone Advisors Pty Ltd, which remain unchanged by the lapse. This entity holds 500,000 fully paid ordinary shares and 2,000,000 performance rights, though the class of these rights is not specified.

The fact that Cornerstone Advisors’ performance rights did not lapse suggests they are subject to different terms, vesting conditions, or expiry dates. The company did not provide further details. Investors seeking a full understanding of director incentives may consult prior updates or the latest Annual Report.

John Smyth’s Aggregate Holdings Across Entities

Consolidating all interests, Smyth’s holdings post-lapse are: 10,500,000 fully paid ordinary shares (direct via Smyth Super Fund); 2,000,000 unlisted options exercisable at $0.09 until 15 July 2027 (direct via Smyth Super Fund); 4,500,000 fully paid ordinary shares (indirect via Clariden Capital Limited); 500,000 fully paid ordinary shares (indirect via Cornerstone Advisors Pty Ltd); and 2,000,000 performance rights (indirect via Cornerstone Advisors Pty Ltd).

In total, Smyth holds 15,500,000 fully paid ordinary shares across all entities, along with 2,000,000 unlisted options and 2,000,000 performance rights. This represents a significant decrease in equity-linked instruments compared to before 29 June 2026, when Clariden Capital Limited also held the 925,342 performance rights now lapsed, reducing potential dilutionary instruments.

Previous Director Interest Notice Dated 3 December 2025

The update notes Smyth’s last director interest notice was filed on 3 December 2025, serving as a benchmark for tracking changes over approximately seven months, during which no other changes were disclosed.

The 29 June 2026 lapse date is near the financial year-end, possibly reflecting timing of performance milestones or expiry schedules. The announcement does not detail original grant dates or conditions. Investors interested in the full history should review prior Appendix 3Y filings or remuneration reports.

No Closed Period Issues Reported

Part 3 of the Appendix 3Y confirms the lapsing did not occur during a closed period when directors are restricted from trading without board clearance. As lapsing is a passive event, no prior written approval was required or obtained. This confirmation enhances transparency regarding governance.

Investor Considerations Following the Update

The lapse of nearly one million performance rights held by a director may prompt investors to assess company progress and incentive structures. Lapsing can indicate unmet milestones but may also result from administrative factors. The announcement provides no specifics on milestones or reasons for lapse, so conclusions should be cautious.

Investors will likely watch for new incentive arrangements and operational updates that clarify the context. Smyth’s retention of 2,000,000 unlisted options exercisable at $0.09 until 15 July 2027 presents a near-term milestone dependent on share price performance over the next year.